Locations:
Search IconSearch

Making a Case for Tubeless Percutaneous Nephrolithotomy

Research supports a tubeless approach in all PCNL cases

690-Monga_HERO-IMAGE_Kidney-Stones-w-Ruler

Previous studies have suggested that a nephrostomy tube be left in percutaneous nephrolithotomy (PCNL) patients who experience significant bleeding or other complications. Throughout the last three years, however, Manoj Monga, MD, has used a tubeless approach in all patients undergoing PCNL unless there was a residual stone that he anticipated being able to access through the same tract.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

As the result of a study led by Dr. Monga and Mark Noble, MD, the doctors propose that tubeless PCNL is safe, irrespective of bleeding, perforation, extravasation or other intraoperative issues that have previously been used as exclusionary criteria for this approach.

Determining safety, efficacy

To determine the safety and efficacy of using a tubeless approach, the researchers evaluated 160 patients who were randomly assigned to tubeless PCNL with an indwelling ureteral stent or a conventional PCNL with a small-bore pigtail nephrostomy catheter. All patients underwent balloon dilation of the nephrostomy tract to 30Fr.

Patients were similar with regard to age, gender, American Society of Anesthesiologists score, number of stones, maximum stone dimension, number of calyces involved and use of preoperative narcotics.

Examining the results

Researchers found that patients who underwent the tubeless approach experienced a significantly shorter hospital stay, less postoperative pain and less narcotic utilization compared with those who underwent a standard approach.

The doctors did not exclude patients based on intraoperative bleeding; patients were identified who had a hemoglobin drop of 1 gram or more during surgery, and in this subgroup there was no difference in hemoglobin on postoperative day one. This suggests that a tube does not help with tamponade in patients with significant intraoperative bleeding.

Indeed, four patients in the conventional PCNL group required transfusion and two required embolization, while no patients in the tubeless PCNL group required either transfusion or embolization.

Advertisement

Monga_Charts_w Caption

Advertisement

Related Articles

Dr. Olivares at the Focal One surgical dashboard
Cleveland Clinic Leads First Transcontinental HIFU Procedure To Treat Prostate Cancer

Historic collaboration connects two Cleveland Clinic locations, enables real-time sharing of metrics and surgical progress

CT scan of female patient bladder cancer
November 26, 2024/Urology & Nephrology/Urology
Use of Interim Imaging To Preserve Eligibility for Vaginal-Sparing Cystectomy

Retrospective study evaluates clinical upstaging during neoadjuvant treatment

Microscopic view of bladder cancer with variant histology
November 19, 2024/Urology & Nephrology/Urology
Nonmuscle Invasive Bladder Cancer With Variant Histology: When To Consider a Bladder-Sparing Approach

Retrospective study finds acceptable cancer control among most histologic subtypes with intravesical therapy

Single-port robot docked in the operating room
November 12, 2024/Urology & Nephrology/Urology
Single-Port Pyeloplasty in a Pediatric Patient: A Novel Surgical Technique

Revolutionizing pediatric urology with a new, less invasive approach

Physician smiles at patient in a preoperative setting
September 12, 2024/Urology & Nephrology/Urology
Improving the Bladder Cancer Survivorship Experience for Women

What updated techniques, counseling and a changing workforce could mean

Surgeons in the operating room with the single-port robot
Novel Single-Port Robotic Urology Surgery Surpasses 1,000 Cases

Applications, outcomes and untapped potential

Photo of Dr. Bajic
Counseling Your Patients on SGLT-2 Inhibitors and Adverse Urologic Outcomes

Retrospective study shows SGLT-2 inhibitors may lead to worse urologic outcomes

Blood test
Review Underscores Impact of Red Blood Cell Disorders on Male Reproduction

Early, individualized diagnosis and comprehensive management key to preserving fertility

Ad